Bank Of America Corp Corbus Pharmaceuticals Holdings, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.11 - $5.46 $22 - $1,119	205 Added 137.58%	354 $0
Q3 2022 Nov 14, 2022	BUY	$0.17 - $5.31 $17 - $546	103 Added 223.91%	149 $0
Q2 2022 Aug 12, 2022	SELL	$0.21 - $0.53 $3 - $9	-17 Reduced 26.98%	46 $0
Q1 2022 May 16, 2022	SELL	$0.32 - $0.67 $207 - $434	-648 Reduced 91.14%	63 $0
Q4 2021 Feb 08, 2022	SELL	$0.6 - $1.11 $391,617 - $724,492	-652,696 Reduced 99.89%	711 $0
Q3 2021 Nov 15, 2021	BUY	$1.01 - $1.82 $587,132 - $1.06 Million	581,319 Added 806.4%	653,407 $666,000
Q2 2021 Sep 13, 2021	BUY	$1.39 - $2.21 $100,202 - $159,314	72,088 New	72,088 $132,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.